|
|
Volumn 28, Issue 2, 2004, Pages 150-160
|
|
Pharmaceuticals, the state and the global harmonisation process.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARTICLE;
CLINICAL TRIAL;
CONFLICT OF INTEREST;
DEVELOPED COUNTRY;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG SURVEILLANCE PROGRAM;
ECONOMIC ASPECT;
ECONOMICS;
ETHICS;
EUROPE;
EUROPEAN UNION;
GOVERNMENT;
HUMAN;
INTERNATIONAL COOPERATION;
JAPAN;
LEGAL ASPECT;
MARKETING;
ORGANIZATION;
ORGANIZATION AND MANAGEMENT;
PUBLIC HEALTH;
SOCIAL BEHAVIOR;
STANDARD;
UNITED STATES;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
CLINICAL TRIALS;
CONFLICT OF INTEREST;
DEVELOPED COUNTRIES;
DRUG APPROVAL;
DRUG INDUSTRY;
ECONOMIC COMPETITION;
EUROPE;
EUROPEAN UNION;
GOVERNMENT AGENCIES;
HUMANS;
INTERNATIONAL AGENCIES;
INTERNATIONAL COOPERATION;
JAPAN;
MARKETING;
ORGANIZATIONAL OBJECTIVES;
PUBLIC HEALTH;
SOCIAL RESPONSIBILITY;
UNITED STATES;
|
|
EID: 16544372219
PISSN: 01565788
EISSN: None
Source Type: Journal
DOI: 10.1071/AH040150 Document Type: Article |
|
Times cited : (12)
|
|
References (0)
|
